Puma Biotechnology Inc (NASDAQ:PBYI) traded at $3.66 at last check on current trade day and made an upward move of 24.07% on its previous day’s price.
Looking at the stock we see that its previous close was $2.95 and the beta (5Y monthly) reads 1.08 with the day’s price range being $3.18 – $3.77. The company has a trailing 12-month PE ratio of 7.71. In terms of its 52-week price range, PBYI has a high of $7.73 and a low of $2.22. The company’s stock has gained about 15.82% over that past 30 days.
Puma Biotechnology Inc has a market cap of $169.87 million and is expected to release its quarterly earnings report in February.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 52.5M, with a low of 51.8M and a high of 53.2M. The median projection represents growth adding up to -27.29% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 223.9M, or -4.97% down from figures reported last year.
On the other hand, looking at the outlook for the PBYI stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Puma Biotechnology Inc (PBYI) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 22.02% off its SMA20 and 22.43% from its 50-day simple moving average. The RSI (14) is pointing at 66.89 while the volatility over the past week is 8.77% and jumps to 7.51% over the past one month. The beta value is 1.09, while the average true range (ATR) is currently pointing at 0.28.
Coming back to Puma Biotechnology Inc (NASDAQ:PBYI), we note that the average 3-month trading volume was 454.26K, while that of the preceding 10-day period stands at 0.65 million. Current shares outstanding are 49.07 million.
The insiders hold 28.99% of the company’s shares while institutions hold 54.36%. The data shows that short shares as of 2024-12-13, stood at 2.91 million at a short ratio of 5.73. This represents a 698.00 short interest in shares outstanding on 2024-12-13. Shares short fall in December from the previous month at 2.98 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 20.00% up in year-to-date price movement.
